Clinical Trial Update: Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

View source ↗

Summary

Post-marketing safety surveillance update assessing adverse events of Kiklin capsules in chronic kidney disease patients on hemodialysis with hyperphosphatemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Kiklin capsules

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis | Status: COMPLETED